Presented ByDr Paolo Strati, MD Anderson Cancer Center, TX, USA
TrialPhase 2 ConferenceASH 2023
7 February, 2024 15:00
Presented ByProf. Francesca Gay, University of Torino, Italy
TrialPhase 3, IsKia ConferenceASH 2023
7 February, 2024 14:57
Presented ByProf. Pieter Sonneveld, Erasmus MC, the Netherlands
TrialPhase 3, Perseus ConferenceASH 2023
6 February, 2024 16:34
Presented ByProf. Salomon Manier, Lille University Hospital, France
TrialPhase 3, CARTITUDE-6 ConferenceEBMT 2023
14 June, 2023 20:23
Presented ByDr Hani Hassoun, Memorial Sloan Kettering Cancer Center, NY, USA
TrialPhase 3, DETERMINATION ConferenceEBMT 2023
14 June, 2023 20:14
ExpertDr Sergio Giralt, Memorial Sloan Kettering Cancer Center, USA
TrialPhase 3, KarMMa-3
17 April, 2023 12:45
Presented ByProf. Shaji Kumar, Mayo Clinic, MN, USA
TrialPhase 2, ASCENT ConferenceASH 2022
20 February, 2023 12:04
Presented ByDr Sara Bringhen, Università degli Studi di Torino, Italy
TrialPhase 4, REAL-MM ConferenceASH 2022
20 February, 2023 11:47
Presented ByProf. Paul Richardson, Harvard Medical School, MA, USA
TrialPhase 3, DETERMINATION ConferenceASCO 2022
5 August, 2022 14:33
Presented ByDr Dominik Dytfeld, Poznan University of Medical Sciences, Poland
TrialPhase 3, ATLAS ConferenceEHA 2022
1 July, 2022 11:24
Presented ByDr Paul Richardson, Dana-Farber Cancer Institute, MA, USA
TrialPhase 3, DETERMINATION ConferenceEHA 2022
1 July, 2022 11:21
Presented ByDr Jacob Laubach, Dana-Farber Cancer Institute, MA, USA
TrialPhase 2, GRIFFIN ConferenceASH 2021
4 February, 2022 11:30
Presented ByDr Eileen Boyle, NYU Langone Health, NY, USA
ConferenceASH 2021
4 February, 2022 11:22
ExpertDr Grzegorz Nowakowski, Mayo Clinic, Rochester, USA
TrialCohort study, RE-MIND2 ConferenceASH 2021
4 February, 2022 11:08
Presented ByProf. Thierry Facon, University of Lille, France
TrialPhase 3, MAIA ConferenceEHA 2021
5 August, 2021 14:46
Presented ByProf. Marco Ladetto, University del Piemonte Orientale, Italy
TrialLOTIS-2 ConferenceEHA 2021
5 August, 2021 11:17
Presented ByProf. Shaji K. Kumar, Mayo Clinica, MN, USA
TrialPhase 3, ENDURANCE (E1A11) ConferenceASCO 2020
28 August, 2020 16:00
TrialMAGNIFY, AUGMENT ConferenceASCO 2019
15 July, 2019 14:17